Total Payments
$8,621
2024 Payments
$1,074
Companies
47
Transactions
641
Medicare Patients
2,101
Medicare Billing
$189,903
Payment Breakdown by Category
Food & Beverage$8,513 (98.8%)
Education$107.75 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,513 | 629 | 98.8% |
| Education | $107.75 | 12 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,055 | 103 | $0 (2024) |
| GlaxoSmithKline, LLC. | $926.46 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $804.23 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $695.33 | 69 | $0 (2022) |
| Amgen Inc. | $554.35 | 32 | $0 (2022) |
| Novo Nordisk Inc | $478.62 | 33 | $0 (2024) |
| Lilly USA, LLC | $434.17 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $417.38 | 29 | $0 (2023) |
| PFIZER INC. | $400.34 | 43 | $0 (2023) |
| Astellas Pharma US Inc | $321.25 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,074 | 66 | ABBVIE INC. ($218.34) |
| 2023 | $1,462 | 109 | AbbVie Inc. ($321.48) |
| 2022 | $1,266 | 92 | Janssen Pharmaceuticals, Inc ($221.66) |
| 2021 | $1,136 | 89 | AbbVie Inc. ($320.37) |
| 2020 | $543.55 | 38 | Allergan, Inc. ($131.78) |
| 2019 | $1,014 | 77 | Amgen Inc. ($178.50) |
| 2018 | $772.17 | 53 | Amgen Inc. ($140.73) |
| 2017 | $1,353 | 117 | Janssen Pharmaceuticals, Inc ($286.13) |
All Payment Transactions
641 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 09/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Cardio-renal | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 285 | 430 | $78,426 | $32,642 |
| 2022 | 9 | 423 | 573 | $103,096 | $43,135 |
| 2021 | 12 | 548 | 737 | $111,951 | $50,063 |
| 2020 | 15 | 845 | 1,169 | $168,012 | $64,063 |
Total Patients
2,101
Total Services
2,909
Medicare Billing
$189,903
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 263 | $54,178 | $20,055 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $18,250 | $8,810 | 48.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 34 | 34 | $3,604 | $2,446 | 67.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,638 | $1,131 | 69.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 21 | $756.00 | $199.92 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 272 | $56,032 | $20,268 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 85 | 85 | $21,250 | $10,535 | 49.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $10,560 | $4,410 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 25 | $6,025 | $3,033 | 50.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $3,604 | $2,314 | 64.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 44 | $1,848 | $1,207 | 65.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 35 | 35 | $1,435 | $608.24 | 42.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 32 | 40 | $1,440 | $383.79 | 26.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 22 | 22 | $902.00 | $376.90 | 41.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 312 | $64,272 | $25,634 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 78 | 78 | $19,500 | $9,912 | 50.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 29 | $6,989 | $3,890 | 55.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 41 | 42 | $4,452 | $2,732 | 61.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 18 | 18 | $3,930 | $2,249 | 57.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 12 | 12 | $3,216 | $1,941 | 60.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 61 | 61 | $2,501 | $1,061 | 42.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 49 | 50 | $2,100 | $791.03 | 37.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 45 | 45 | $1,845 | $782.55 | 42.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 39 | 55 | $1,980 | $534.05 | 27.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 19 | 19 | $798.00 | $296.11 | 37.1% |
About Dr. Michael Bodin, MD
Dr. Michael Bodin, MD is a Family Medicine healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376743427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bodin, MD has received a total of $8,621 in payments from pharmaceutical and medical device companies, with $1,074 received in 2024. These payments were reported across 641 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,513).
As a Medicare-enrolled provider, Bodin has provided services to 2,101 Medicare beneficiaries, totaling 2,909 services with total Medicare billing of $189,903. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Gonzales, LA
- Active Since 07/18/2007
- Last Updated 01/14/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376743427
Products in Payments
- VRAYLAR (Drug) $648.96
- TRELEGY ELLIPTA (Drug) $513.49
- XARELTO (Drug) $492.84
- JARDIANCE (Drug) $426.75
- UBRELVY (Drug) $379.03
- FARXIGA (Drug) $297.70
- Kerendia (Drug) $264.44
- STIOLTO RESPIMAT (Drug) $227.63
- Aimovig (Biological) $203.78
- TRULICITY (Drug) $199.57
- INVOKANA (Drug) $196.47
- BELSOMRA (Drug) $180.61
- Ozempic (Drug) $178.46
- MOUNJARO (Drug) $151.10
- MYRBETRIQ (Drug) $145.55
- Prolia (Biological) $144.90
- FREESTYLE LIBRE 3 (Device) $141.67
- QULIPTA (Drug) $140.84
- Santyl (Drug) $132.17
- TOUJEO (Drug) $124.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Gonzales
Robert St. Amant, M.d, M.D
Family Medicine — Payments: $236,984
Family Medicine $236,984
Dr. Ericka Flood, M.d, M.D
Family Medicine — Payments: $15,507
Family Medicine $15,507
Richard Caro, M.d, M.D
Family Medicine — Payments: $9,983
Family Medicine $9,983
Gertrude Gboloo, M.d, M.D
Family Medicine — Payments: $7,934
Family Medicine $7,934
Shawn Hall, M.d, M.D
Family Medicine — Payments: $6,468
Family Medicine $6,468
Dr. Garth Vaz, M.d, M.D
Family Medicine — Payments: $5,528
Family Medicine $5,528